Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2007, Vol. 109, No. 5, pp. 2014-2022.
Prepublished online as a Blood First Edition Paper on October 24, 2006; DOI 10.1182/blood-2006-07-035279.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2006-07-035279v1
109/5/2014    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crellin, N. K
Right arrow Articles by Levings, M. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crellin, N. K
Right arrow Articles by Levings, M. K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 13, 2006
Accepted October 12, 2006

Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells

Natasha K Crellin, Rosa V Garcia, and Megan K Levings*

University of British Columbia, Canada
Vancouver Coastal Health Research Institute, Canada

* Corresponding author; email: mlevings{at}interchange.ubc.ca.

Suppression by T regulatory cells (Tregs) is a major mechanism by which the immune system controls responses to self and non-harmful foreign proteins. Although there are many different types of Treg cells, the best characterized are those that constitutively express cell-surface IL-2R{alpha} (CD25). We investigated whether altered TCR-mediated signaling in pure populations of ex vivo human CD4+CD25+ Tregs might underlie their unique phenotype, including hyporesponsiveness to T cell receptor mediated activation and lack of cytokine production. CD4+CD25+ Tregs displayed a consistent defect in phosphorylation of AKT at serine 473, and reduced phosphorylation of the AKT substrates FOXO and S6. Restoration of AKT activity via lenti-viral mediated expression of an inducibly active form of the kinase revealed that reduced activity of this pathway was necessary for the suppressive function of CD4+CD25+ Tregs. These data represent the first demonstration of a causal association between altered signaling and the function of CD4+CD25+ Tregs. Moreover, we have created the first system allowing inducible abrogation of suppression through manipulation of the suppressor cells. This system will be a powerful tool to further study the mechanism(s) of suppression by CD4+CD25+ Tregs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
S. Haxhinasto, D. Mathis, and C. Benoist
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
J. Exp. Med., March 17, 2008; 205(3): 565 - 574.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zeiser, D. B. Leveson-Gower, E. A. Zambricki, N. Kambham, A. Beilhack, J. Loh, J.-Z. Hou, and R. S. Negrin
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood, January 1, 2008; 111(1): 453 - 462.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020